Transcatheter valve replacement for badly calcified heart valves
Part of Heart & circulation clinical trials.
This trial tests Prizvalve, a catheter-based procedure to replace a severely damaged “atrioventricular” valve in people at high risk from open-heart surgery. It may help reduce symptoms caused by valve narrowing or leaking when traditional surgery is not a good option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your heart ultrasound shows your atrioventricular valve has moderate or severe calcification and disease (leaking, narrowing, or both)
- You have symptoms and your heart failure symptoms are at least Class II
- You are 18 or older, and you are not pregnant or breastfeeding
- A heart team says a catheter valve replacement could help you and fits your heart anatomy
- You’re likely too high-risk for standard surgery (for example, STS risk above 8%) or you cannot have surgery because of severe valve calcification
- You can understand the study and agree to follow all visits and tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies Prizvalve Pro™, a new transcatheter (catheter-based) aortic valve replacement, for people with severe aortic valve narrowing who are too high-risk for standard surgery. It may help your heart work better and improve symptoms by replacing the failing valve without open-heart surgery.
This trial studies whether a minimally invasive “clip” procedure can safely improve tricuspid valve leakage (a heart valve that doesn’t close tightly). It focuses on older adults who are considered too high-risk for open-heart surgery and still have enough heart pumping strength to benefit.
This trial tests a new type of artificial heart valve made of polymer (a special plastic-like material) for people with severe aortic valve disease. It aims to see if the valve is safe and works well, giving you an option for a replacement valve that might last longer.
This trial tests a new replacement valve (Prizvalve) for people whose bioprosthetic heart valve is worn out (narrowed or leaky). It is designed for those who are at high risk for another open-heart surgery.
This trial tests a new catheter-based device to replace your tricuspid valve without open-heart surgery. It's for people with severe tricuspid regurgitation who are at high risk for surgery.
This trial tests a new valve device placed through a small tube (catheter) to treat severe aortic stenosis, a condition where the aortic valve is narrowed and doesn't open fully. It's for patients who cannot have traditional open-heart surgery.
Hear when a new Atrioventricular Annular Calcification trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.